newsfilter
← Latest News
PR Newswire·

DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

CUPERTINO, Calif., July 20, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ